Concepedia

Author

Andrew Belch

Alberta Cancer Foundation

Also Known As

A Belch, A. Belch, Andrew Belch, Andrew J. Belch

14

Publications

712

Citations

9

H-Index

33

Concepts

All Affiliations

Alberta Cancer FoundationOntario Institute for Cancer Research
AB

About

Andrew Belch is an author at Alberta Cancer Foundation specializing in medicine, oncology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

343

2

Immunology

2

2

73

3

Health Sciences

1

1

214

4

Biochemistry

1

1

27

5

Marrow Transplantation

1

1

31

Andrew Belch

×

8

Publications

656

Citations

8

H-Index

YearCitations

Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

C. Tom Kouroukis, Andrew Belch, Michael Crump,

Journal of Clinical Oncology

2003

280

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Thierry Façon, Meletios Α. Dimopoulos, Nathalie Meuleman,

Leukemia

2019

214

An international multi-centre, randomized, open-label, phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III/IV follicular non-Hodgkins lymphoma.

Robert Marcus, Kevin Imrie, Andrew Belch,

Ghent University Academic Bibliography (Ghent University)

2003

42

Phase II Trial of Bortezomib in Mantle Cell Lymphoma.

Andrew Belch, C. Tom Kouroukis, Michael Crump,

Blood

2004

33

Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism.

Mark D. Minden, Hans A. Messner, Andrew Belch

Journal of Clinical Investigation

1985

31

Hemolysis in mice treated with deoxycoformycin, am inhibitor of adenosine deaminase

Camila M. Smith, Andrew Belch, J. Frank Henderson

Biochemical Pharmacology

1980

27

Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study

Raul C. Urtasun, Martin Palmer, B. Kinney,

International Journal of Radiation Oncology*Biology*Physics

1998

19

P104 Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases

Mei Zheng, Lawrence Rosen, David Gordon,

The Breast

2005

10

Page 1